UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody

Journal of Virology, 2012-12, Vol.86 (23), p.12923-12932

2012

Link zum Volltext

Verfügbarkeit prüfen

Genotype-Dependent Sensitivity of Hepatitis C Virus to Inhibitors of the p7 Ion Channel

Hepatology (Baltimore, Md.), 2008-12, Vol.48 (6), p.1779-1790

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

Journal of Virology, 2006-09, Vol.80 (17), p.8695-8704

2006

Link zum Volltext

Verfügbarkeit prüfen

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

Journal of general virology, 2008-03, Vol.89 (3), p.653-659

2008

Link zum Volltext

Verfügbarkeit prüfen

Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies

Journal of Virology, 2010-06, Vol.84 (11), p.5494-5507

2010

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33

Hepatology (Baltimore, Md.), 2006-03, Vol.43 (3), p.592-601

2006

Link zum Volltext

Verfügbarkeit prüfen

Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design

npj vaccines, 2021-01, Vol.6 (1), p.7-10, Article 7

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions

Journal of Virology, 2007-01, Vol.81 (2), p.1043-1047

2007

Link zum Volltext

Verfügbarkeit prüfen

Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil

PLoS neglected tropical diseases, 2016-10, Vol.10 (10), p.e0005048-e0005048

2016

Link zum Volltext

Verfügbarkeit prüfen

Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33

Journal of general virology, 2007-11, Vol.88 (11), p.2991-3001

2007

Link zum Volltext

Verfügbarkeit prüfen

Genotype‐dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel

Hepatology (Baltimore, Md.), 2008-12, Vol.48 (6), p.1779-1790

2008

Link zum Volltext

Verfügbarkeit prüfen

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

Journal of general virology, 2009-01, Vol.90 (1), p.48-58

2009

Link zum Volltext

Verfügbarkeit prüfen

Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein

Journal of general virology, 2010-01, Vol.91 (1), p.122-132

2010

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure–function relationships

Journal of general virology, 2011-10, Vol.92 (Pt 10), p.2249-2261

2011

Link zum Volltext

Verfügbarkeit prüfen

Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry

Protein & cell, 2010-07, Vol.1 (7), p.664-674

2010

Link zum Volltext

Verfügbarkeit prüfen

Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins

Methods in molecular biology (Clifton, N.J.), 2007, Vol.379, p.177

2007

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Core Protein Interacts with a Human DEAD Box Protein DDX3

Virology (New York, N.Y.), 1999-05, Vol.257 (2), p.330-340

1999

Link zum Volltext

Verfügbarkeit prüfen

Results of a large scale screen of microalgae for the production of protease inhibitors

Planta medica, 1988-02, Vol.54 (1), p.10-14

1988

Link zum Volltext

Verfügbarkeit prüfen

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B

Journal of hepatology, 1998-09, Vol.29 (3), p.345-351

1998

Link zum Volltext

Verfügbarkeit prüfen

Generation of anti-peptide and anti-protein sera effect of peptide presentation on immunogenicity

Journal of immunological methods, 1991-03, Vol.137 (2), p.149-157

1991

Link zum Volltext

Verfügbarkeit prüfen

Microalgae and cyanobacteria as a source of glycosidase inhibitors

Journal of general microbiology, 1987-07, Vol.133 (7), p.1701

1987

Link zum Volltext

Verfügbarkeit prüfen

Results of a large-scale screening programme to detect antibacterial activity from freshwater algae

British phycological journal, 1988-03, Vol.23 (1), p.41-44

1988

Link zum Volltext

Verfügbarkeit prüfen

Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection

Journal of virology, 2016-08, Vol.90 (16), p.7456-7468

2016

Link zum Volltext

Verfügbarkeit prüfen

Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity

Journal of medical virology, 2004-03, Vol.72 (3), p.370-376

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(7)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody

Genotype-Dependent Sensitivity of Hepatitis C Virus to Inhibitors of the p7 Ion Channel

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33

Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design

Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions

Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil

Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33

Genotype‐dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein

Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure–function relationships

Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry

Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins

Hepatitis C Virus Core Protein Interacts with a Human DEAD Box Protein DDX3

Results of a large scale screen of microalgae for the production of protease inhibitors

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B

Generation of anti-peptide and anti-protein sera effect of peptide presentation on immunogenicity

Microalgae and cyanobacteria as a source of glycosidase inhibitors

Results of a large-scale screening programme to detect antibacterial activity from freshwater algae

Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection

Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity

Suchergebnisse filtern